United States · FDA National Drug Code directory
Ciprofloxacin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-2097_4ce9e08d-d08d-474c-b07a-e1832623ae74
- Product NDC
- 71335-2097
- Form
- TABLET, COATED
- Composition / generic term
- Ciprofloxacin
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200812
- Source listing expiry
- 20271231
Source-listed ingredients
- CIPROFLOXACIN HYDROCHLORIDE — 250 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 7 TABLET, COATED in 1 BOTTLE (71335-2097-0) · 71335-2097-0
- 20 TABLET, COATED in 1 BOTTLE (71335-2097-1) · 71335-2097-1
- 10 TABLET, COATED in 1 BOTTLE (71335-2097-2) · 71335-2097-2
- 14 TABLET, COATED in 1 BOTTLE (71335-2097-3) · 71335-2097-3
- 6 TABLET, COATED in 1 BOTTLE (71335-2097-4) · 71335-2097-4
- 30 TABLET, COATED in 1 BOTTLE (71335-2097-5) · 71335-2097-5
- 60 TABLET, COATED in 1 BOTTLE (71335-2097-6) · 71335-2097-6
- 12 TABLET, COATED in 1 BOTTLE (71335-2097-7) · 71335-2097-7
- 40 TABLET, COATED in 1 BOTTLE (71335-2097-8) · 71335-2097-8
- 90 TABLET, COATED in 1 BOTTLE (71335-2097-9) · 71335-2097-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →